A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapy-Reference-Cited by-同舟云学术

A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapy

Published:2021-04-13 Issue:4 Volume:24 Page:1063-1072
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Li Joseph K. M.^ORCID,Wang Lynn L.,Wong Christine Y. P.,Chiu Peter K. F.^ORCID,Teoh Jeremy Y. C.^ORCID,Kwok Hilda S. W.,Leung Steven C. H.^ORCID,Wong Sunny H.,Tsui Stephen K. W.,Ng Chi-Fai^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

https://www.nature.com/articles/s41391-021-00360-1.pdf

Reference57 articles.

1. Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer. JAMA. 2005;294:238–44.

2. Teoh JYC, Chiu PKF, Chan SYS, Poon DMC, Cheung H-Y, Hou SSM, et al. Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer. Aging Male. 2015;18:180–5.

3. Smith MR. Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors. Curr Urol Rep. 2008;9:197–202.

4. Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol. 2009;181:1998–2008.

5. Levine GN, D’Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation. 2010;121:833–40.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cross‐species analysis of fecal microbiomes in humans and mice reveals similarities and dissimilarities associated with prostate cancer risk;The Prostate;2024-08-07

2. Gut microbiome: a novel preventive and therapeutic target for prostatic disease;Frontiers in Cellular and Infection Microbiology;2024-07-29

3. Vaginal microbial profile of cervical cancer patients receiving chemoradiotherapy: the potential involvement of Lactobacillus iners in recurrence;Journal of Translational Medicine;2024-06-17

4. Metabolic Response to Androgen Deprivation Therapy of Prostate Cancer;Cancers;2024-05-24

5. The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids;Nature Communications;2024-04-23